Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 14 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
131 30.7 months Advanced breast cancer 4 Chemotherapy
Oslo University Hospital Norway 1/2012
Treatment Details: Patients: This phase II study involved women with advanced or metastatic breast cancer. The patients were divided into two separate treatment groups. Group A consisted of 19 patients with
 
132 30.6 months Unresectable colorectal cancer metastases to liver 5 Chemotherapy
Surgery
Saint John's Health Center United States 3/2002
Treatment Details: Patients: This Phase II study involved 185 patients with unresectable colorectal hepatic (liver) metastases that had gotten worse (i.e. progressed by CT and/or CEA levels) while these patie
 
133 30.6 months Unresectable colorectal cancer metastases to liver 5 Chemotherapy
Surgery
Saint John's Health Center United States 3/2002
Treatment Details: Patients: This Phase II study involved 185 patients with unresectable colorectal hepatic (liver) metastases that had gotten worse (i.e. progressed by CT and/or CEA levels) while these patie
 
134 30.5 months B-cell non-Hodgkin's lymphoma 5 Biologic therapy
Chemotherapy
Hormone
Immunotherapy
Mayo Clinic and Mayo Foundation United States 6/2008
Treatment Details: Patients: This phase II study involved 57 patients with B-cell non-Hodgkin’s lymphoma who had relapsed following prior treatment. The median patient age was 63 years and 67% were male.
 
135 30.4 months Epithelial ovarian cancer, fallopian tube, or primary peritoneal cancer 4 Chemotherapy
Sloan-Kettering Cancer Center United States 10/2007
Treatment Details: Patients: This phase III study involved 280 women ranging in age from 24.4 to 85.8 years old. These patients had stage III or IV epithelial ovarian cancer, fallopian tube, or primary perit
 
136 30.3 months Metastatic, Castration-Resistant Prostate Cancer 5 Hormone
UCSF Helen Diller Family Comprehensive Cancer Center United States 2/2015
Treatment Details: Patients: This phase 3 study involved chemotherapy-naïve metastatic castration-resistant prostate cancer patients who were separated into two treatment groups. Group A consisted of 546 pati
 
137 30.2 months Metastatic breast cancer or locally recurrent breast cancer 5 Biologic therapy
Chemotherapy
Mount Vernon Hospital United Kingdom 7/2010
Treatment Details: Patients: This study involved female patients with locally recurrent or metastatic breast cancer. Patients were divided into 3 separate treatment groups. Group A consisted of 241 patients
 
138 30.0 months Androgen-independent prostate cancer 5 Biologic therapy
Chemotherapy
Immunotherapy
M. D. Anderson Cancer Center United States 11/2007
Treatment Details: Patients: This phase II study involved 150 patients with androgen-independent prostate cancer. The majority (100) of the men were between the ages of 50 and 70 years old. These patients ha
 
139 30.0 months Metastatic colorectal cancer 4 Biologic therapy
Chemotherapy
Vall d'Hebron University Hospital Spain 11/2007
Treatment Details: Patients: This phase II study involved 62 patients with metastatic colorectal cancer. The median age was 65 years, ranging from 43 to 78. Thirty of these patients were men, and 13 were wo
 
140 30.0 months unresectable metastatic colorectal cancer 3 Chemotherapy
Surgery
University of Louisville School of Medicine United States 4/2006
Treatment Details: Patients: This Phase II study involved 21 patients (8 men, 13 women, median age 55) with advanced colorectal cancer with unresectable liver metastases. All patients received chemotherapy be
 
Page 14 of 187  | Previous Page  | Next Page